Talaromyces marneffei activates the AIM2-caspase-1/-4-GSDMD axis to induce pyroptosis in hepatocytes.
Talaromyces marneffei activates the AIM2-caspase-1/-4-GSDMD axis to induce pyroptosis in hepatocytes.
复制标题
DOI:
10.1080/21505594.2022.2080904
复制
发表时间:
2022-12
期刊:
影响因子:
5.2
通讯作者:
Ye, Li
中科院分区:
文献类型:
--
作者:
Wang, Gang;Wei, Wudi;Jiang, Zhongsheng;Jiang, Junjun;Han, Jing;Zhang, Hong;Hu, Jiaguang;Zhang, Peng;Li, Xu;Chen, Tao;He, Jinhao;Li, Zhen;Lai, Jingzhen;Liang, Hao;Ning, Chuanyi;Ye, Li
Talaromyces marneffei tends to induce systemic infection in immunocompromised individuals, which is one of the causes of the high mortality. The underlying molecular mechanisms of T.marneffei-induced abnormal liver function are still poorly understood. In this study, we found that T.marneffei-infected patients could develop abnormal liver function, evidenced by reduced albumin and increased levels of aspartate aminotransferase (AST) and AST/alanine aminotransferase (ALT). T. marneffei-infected mice exhibited similar characteristics. In vitro investigations showed that T.marneffei induced the death of AML-12 cells. Furthermore, we determined that T.marneffei infection induced pyroptosis in hepatocytes of C57BL/6J mice and AML-12 cells, demonstrated by the increase of AIM2, caspase-1/-4, Gasdermin D(GSDMD) and pyroptosis-related cytokines in T.marneffei-infected mice/cells. Importantly, cell death was markedly suppressed in the presence of VX765 (an inhibitor of caspase-1/-4). Furthermore, in the presence of VX765, T.marneffei-induced pyroptosis was blocked. Nevertheless, necroptosis and apoptosis were also detected in infected animal model at 14 days post-infection. In conclusion, T.marneffei induces pyroptosis in hepatocytes through activation of the AIM2-caspase-1/-4-GSDMD axis, which may be an important cause of liver damage, and other death pathways including necroptosis and apoptosis may also be involved in the later stage of infection.
登录
查看更多内容
影响因子:
7.3
作者:
Jiang W;Deng Z;Dai X;Zhao W
通讯作者:
Zhao W
影响因子:
64.5
作者:
Karki R;Lee E;Place D;Samir P;Mavuluri J;Sharma BR;Balakrishnan A;Malireddi RKS;Geiger R;Zhu Q;Neale G;Kanneganti TD
通讯作者:
Kanneganti TD
影响因子:
11.1
作者:
Guo, Xiaoli;Zhong, Wen;Gao, Ai
通讯作者:
Gao, Ai
影响因子:
15.9
作者:
Kupz, Andreas;Zedler, Ulrike;Kaufmann, Stefan H. E.
通讯作者:
Kaufmann, Stefan H. E.
影响因子:
10
作者:
Floto RA;Olivier KN;Saiman L;Daley CL;Herrmann JL;Nick JA;Noone PG;Bilton D;Corris P;Gibson RL;Hempstead SE;Koetz K;Sabadosa KA;Sermet-Gaudelus I;Smyth AR;van Ingen J;Wallace RJ;Winthrop KL;Marshall BC;Haworth CS;US Cystic Fibrosis Foundation and European Cystic Fibrosis Society
通讯作者:
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society